• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. APTIMA COMBO 2 ASSAY; DNA-REAGENTS, NEISSERIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. APTIMA COMBO 2 ASSAY; DNA-REAGENTS, NEISSERIA Back to Search Results
Catalog Number ASY-13822
Medical Device Problem Code Imprecise or Erratic Results (4059)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/07/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Hologic reviewed the panther logs and worklists and noted there were no indications of hardware or reagent preparation issues that affected results.Customer noted that they ran environmental swabs and received no indication of contamination.Hologic performed a risk assessment and noted no product impact.Hologic has not been informed of any adverse patient outcomes related to this issue.
 
Event or Problem Description
On (b)(6) 2025, customer reported to hologic that they received discrepant chlamydia trachomatis (ct) results on three samples while using the aptima combo 2 assay (ac2, ml (b)(6)) on their panther fusion plus instrument (sn (b)(6)).On (b)(6) 2025, customer tested three sample ids (sids) (b)(6) on panther fusion plus worklist (wl) (b)(4) and received ct positive, ct positive, and ct negative results, respectively.Customer reported out these sample results.Customer suspected possible contamination due to hardware errors in the day following the initial test and decided to retest these samples on a different panther instrument (sn (b)(6)) under wl (b)(4).Upon retest, customer received ct negative, ct negative, and ct positive results for these samples sid (b)(6), respectively.Customer amended the initial results with the retest results and reported them out.Customer did not have additional patient information.Hologic has not been informed of any adverse patient outcomes related to this issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
APTIMA COMBO 2 ASSAY
Common Device Name
DNA-REAGENTS, NEISSERIA
Manufacturer (Section D)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer (Section G)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer Contact
grace nareau
10210 genetic center drive
san diego, CA 92121
8584108040
MDR Report Key23426132
Report Number2024800-2025-00067
Device Sequence Number9626477
Product Code LSL
UDI-Device Identifier15420045505711
UDI-Public15420045505711
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K111409
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 10/30/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Catalogue NumberASY-13822
Device Lot Number912327
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/07/2025
Initial Report FDA Received Date10/30/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device A
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-